🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT05237908
Active, not recruiting Observational

Clinical Outcome and Fusion Rate of 3D Printed Interbody Fusion Cages and Titanium Coated PEEK Cages

NCT05237908 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2022-02-18
Last updated
2026-07-01

Condition(s) studied

Disk Herniated LumbarDisc Disease DegenerativeSpondylolisthesis

Investigational drug(s) / intervention(s)

Transforaminal Lumbar Interbody Fusion

Transforaminal Lumbar Interbody Fusion: Interbody Fusion means the operative immobilization or ankylosis of two or more vertebrae by fusion of the vertebral bodies with a short bone graft or often with diskectomy or laminectomy. (From Blauvelt and Nelson, A Manual of Orthopaedic Terminology, 5th ed, p236; Dorland, 28th ed

Study summary

Prospective, Randomized, Single-Blind Study for the Evaluation of the Clinical Outcome and the Fusion Rate of 3D Printed Interbody Fusion Cages and Titanium Coated PEEK Cages in Transforaminal Lumbar Interbody Fusion

Eligibility

Sex
ALL
Min age
18 Years
Max age
79 Years
Healthy volunteers
No
Inclusion Criteria: * Indication for one, two or three-segment lumbar interbody fusion according to Instructions for use * Written informed consent for the documentation of clinical and radiological results * Willingness and mental ability to participate at the follow-up examinations Exclusion Criteria: * Patient is not willing or able to participate at the follow-up examination * Patient age \< 18 years and \>80 years * Patient is pregnant * Previous instrumented lumbar spine surgery

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
BG Unfallklinik Frankfurt am Main Frankfurt am Main Hesse

More Aesculap AG trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05237908 on ClinicalTrials.gov ↗ ← All trials in Germany